Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (71)
  • Open Access

    REVIEW

    The Versatile Role of Period Circadian Regulators (PERs) in Oral Squamous Cell Carcinoma

    Mei Huang, Zhenyu Zhang, Yuqi Luo, Yuqi Wu, Dan Pan, Yu Zhou*, Xiaobo Luo, Yuchen Jiang*

    BIOCELL, Vol.49, No.6, pp. 961-980, 2025, DOI:10.32604/biocell.2025.062918 - 24 June 2025

    Abstract This review explores the pivotal role of circadian rhythm regulators, particularly the PER genes, in Oral Squamous Cell Carcinoma (OSCC). As key constituents of the biological clock, PERs exhibit a downregulated expression pattern in OSCC, and the expression levels of PERs in OSCC patients are correlated with a favorable prognosis. PERs impact the occurrence and development of OSCC through multiple pathways. In the regulation of cell proliferation, they can function not only through cell cycle regulation but also via metabolic pathways. For example, PER1 can interact with receptors for activated C kinase 1 (RACK1) and… More >

  • Open Access

    REVIEW

    Molecular insights into immune evasion in head and neck squamous cell carcinomas: Toward a promising treatment strategy

    HYEON JI KIM1,#, BO KYUNG JOO1,#, JIN-SEOK BYUN2,3,*, DO-YEON KIM1,3,*

    Oncology Research, Vol.33, No.6, pp. 1271-1282, 2025, DOI:10.32604/or.2025.062207 - 29 May 2025

    Abstract Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive and devastating disease arising primarily from the mucosal epithelium of the oral cavity, pharynx, and larynx. HNSCC ranks as the sixth most common cancer worldwide, carrying significant morbidity and mortality. HPV-positive HNSCC can be partially prevented with the FDA-approved HPV vaccine and generally exhibits a more favorable prognosis compared to HPV-negative cases. However, effective screening and treatment approaches remain elusive for HPV-negative HNSCC. While precancerous lesions may precede invasive cancer in certain situations, most patients present with advanced disease without prior indication of precancerous More >

  • Open Access

    RETRACTION

    Retraction: Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis

    Oncology Research Editorial Office

    Oncology Research, Vol.33, No.6, pp. 1509-1509, 2025, DOI:10.32604/or.2024.062048 - 29 May 2025

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    Gallic acid suppresses esophageal squamous cell carcinoma progression and enhances cisplatin chemosensitivity through IL-6/STAT3/Notch pathway

    NURAN BEDOLLA#, HAO WU#, LINYU LIU, XUETING LIU, YANLI REN*

    Oncology Research, Vol.33, No.6, pp. 1473-1484, 2025, DOI:10.32604/or.2025.060151 - 29 May 2025

    Abstract Background: Gallic acid (GA), a plant-derived polyphenol, possesses diverse biological functions such as reducing inflammation and against tumors. Currently, the influence of GA on the resistance of esophageal squamous cell carcinoma (ESCC) cells to cisplatin (DDP) is not well understood. Methods: Cell counting kit-8 assay examined how GA affected KYSE30 and TE-1 cell viability. 5-Ethynyl-2′-deoxyuridine and TdT-mediated dUTP Nick-End labeling staining detected cell proliferation and apoptosis. Clone formation assay, flow cytometry, Carboxyfluorescein diacetate succinimidyl ester fluorescent probes, and Transwell assay determined cell biological properties, and 2′,7′-Dichlorofluorescin diacetate (DCFH-DA) fluorescent probes detected oxidative stress levels. Signal… More > Graphic Abstract

    Gallic acid suppresses esophageal squamous cell carcinoma progression and enhances cisplatin chemosensitivity through IL-6/STAT3/Notch pathway

  • Open Access

    ARTICLE

    Picropodophyllotoxin: A Natural Epimer Targeting STAT3 Phosphorylation and ROS-Mediated Apoptosis in Oral Squamous Cell Carcinoma Cells

    Jung-Il Chae1,#, Ji-Hye Seo1,#, Goo Yoon2, Young-Joo Jeon3,*, Woo-Keun Kim4,*

    BIOCELL, Vol.49, No.4, pp. 647-663, 2025, DOI:10.32604/biocell.2025.062137 - 30 April 2025

    Abstract Background: Picropodophllotoxin (PPT), a principal component of Podophyllum hexandrum root, demonstrates various beneficial biological activities in multiple cancer types, including antitumor and antiproliferative properties. Despite its known effects, the specific mechanisms by which PPT induces apoptosis in oral squamous cell carcinoma (OSCC) cells lack full clarification. Aims: This study aimed to evaluate the role of PPT in inducing apoptosis in OSCC cells by targeting signal transducer and activator of transcription 3 (STAT3) and to investigate the underlying molecular pathways. Methods: Human OSCC cell lines (HN22 and HSC4) were treated with PPT. Cell viability, colony formation, and apoptotic… More >

  • Open Access

    ARTICLE

    Mistletoe Lectin Induces Apoptosis and Modulates the Cell Cycle in YD38 Oral Squamous Cell Carcinoma Cells

    Chang-Eui Hong1, Su-Yun Lyu2,*

    BIOCELL, Vol.49, No.2, pp. 269-288, 2025, DOI:10.32604/biocell.2025.060411 - 28 February 2025

    Abstract Objectives: Despite progress in therapeutic interventions, squamous cell carcinoma of the oral cavity (OSCC) continues to pose a substantial burden on public health, with persistently poor patient outcomes. This investigation examines the growth-inhibitory and mechanistic effects of a plant-derived protein, Viscum album var. coloratum agglutinin (VCA), extracted from Korean mistletoe, against YD38 OSCC cells. Methods: The experimental protocols involved treating YD38 cells derived from human OSCC with escalating doses of VCA. Cell survival rates were quantified through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric analysis. Changes in apoptotic indices and cell cycle distribution were evaluated using flow cytometric techniques. Protein… More >

  • Open Access

    REVIEW

    Research progress on the role of decorin in the development of oral mucosal carcinogenesis

    YONG RAO1,3,4, XIAO CHEN5,6, KAIYU LI1,3,4, MINHAI NIE1,3,4, XUQIAN LIU2,3,4,*

    Oncology Research, Vol.33, No.3, pp. 577-590, 2025, DOI:10.32604/or.2024.053119 - 28 February 2025

    Abstract Decorin (DCN) is primarily found in the connective tissues of various parts of the body, including the lungs, kidneys, bone tissue, aorta, and tendons. It is an important component of the extracellular matrix (ECM) and belongs to the class I small leucine-rich proteoglycans family. DCN is increasingly attracting attention due to its significant role in tumors, fibrotic diseases, and the regulation of vascular formation. Moreover, its anti-tumor properties have positioned it as a promising biomarker in the fight against cancer. Numerous studies have confirmed that DCN can exert inhibitory effects in various solid tumors, particularly… More >

  • Open Access

    ARTICLE

    Terpinen-4-ol suppresses proliferation and motility of cutaneous squamous cell carcinoma cells by enhancing calpain-2 expression

    DONGYUN RONG1,2,#, YUSHEN SU1,#, ZHIRUI ZENG3, YAN YANG4, HONGUAN LU1,*, YU CAO1,*

    Oncology Research, Vol.33, No.3, pp. 605-616, 2025, DOI:10.32604/or.2024.050661 - 28 February 2025

    Abstract Background: Terpinen-4-ol (T4O), a key constituent of tea tree essential oil and various aromatic plants, has shown promising antiproliferative and pro-apoptotic effects in melanoma and other cancer types. However, its efficacy against cutaneous squamous cell carcinoma (cSCC) remains unclear. Thus, in this study, we investigated the in vivo and in vitro effects of T4O on cSCC cell lines and preliminarily explored its impacting pathways. Methods: Using CCK8 and assay colony formation, we assessed the viability of cSCC A431, SCL-1, and COLO-16 cells treated with T40 at varying concentrations (0, 1, 2, and 4 μM). Flow cytometry was… More >

  • Open Access

    REVIEW

    Insights on Bmi-1 therapeutic targeting in head and neck cancers

    JESSIE REYES-CARMONA*

    Oncology Research, Vol.33, No.2, pp. 301-307, 2025, DOI:10.32604/or.2024.053764 - 16 January 2025

    Abstract The B lymphoma Mo-MLV insertion region 1 homolog (Bmi-1) protein of the polycomb complex is an essential mediator of the epigenetic transcriptional silencing by the chromatin structure. It has been reported to be crucial for homeostasis of the stem cells and tumorigenesis. Though years of investigation have clarified Bmi-1’s transcriptional regulation, post-translational modifications, and functions in controlling cellular bioenergetics, pathologies, and DNA damage response, the full potential of this protein with so many diverse roles are still unfulfilled. Bmi-1 is overexpressed in many human malignancies. Unraveling the Bmi-1’s precise functional role in head and neck… More >

  • Open Access

    ARTICLE

    CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma

    CHUAN JIANG1,2, CHUNLEI LIU1,3, XI YAO1,3, JINGYA SU1,2, WEI LU1,3, ZHENGBO WEI3,*, YING XIE1,2,*

    Oncology Research, Vol.32, No.12, pp. 1935-1948, 2024, DOI:10.32604/or.2024.052244 - 13 November 2024

    Abstract Background: Head and neck squamous cell carcinoma (HNSCC) is a prevalent form of cancer globally, with chemoresistance posing a major challenge in treatment outcomes. The efficacy of the commonly used chemotherapeutic agent, cisplatin, is diminished in patients with poor prognoses. Methods: Various bioinformatics databases were utilized to examine Carboxylesterase 1 (CES1) gene expression, clinicopathologic features, patient survival analysis, and gene function. An organoid model of HNSCC was established, along with the induction of drug-resistant HNSCC in the organoid model. CES1 expression was assessed using qRT-PCR and Western Blot, and differential markers were identified through transcriptome… More >

Displaying 11-20 on page 2 of 71. Per Page